卵巢勃勒纳瘤-治疗管理
目的:勃勒纳卵巢肿瘤以良性为主，恶性仅占1%。仅由恶性勃勒纳瘤(MBT)组成的卵巢癌极为罕见。文献中只报道了少数病例。我们报告一例卵巢MBT并复习文献。方法:一名62岁女性，右侧卵巢细胞核分级(3级和4级)高，延伸至子宫和膀胱，随访MBT。行全子宫切除伴双侧输卵管卵巢切除伴盆腔淋巴结切除术。疾病被分类为pT3cN1R1, FIGO(妇产科学联合会)IIIC期。就疾病的程度而言，一线化疗方案最终在随后的手术中得到了验证。结果:患者接受卡铂-紫杉醇7个疗程的化疗。但细胞减少量不足以进行手术。 Surveillance to 2 months objectified progression of the disease in abdominal lymph node. The patient received consecutively 5 lines of systemic therapy. The patient had an altered general condition and died at 33 months of diagnosis. Conclusion: MBTs ovary are extremely rare and there is no consensus on the therapeutic management of metastatic forms. Taking charge of systemic unfortunately rare cases reported has not been detailed. It seems necessary to identify all cases diagnosed in a database, and in order to harmonize the treatment of this rare disease.
NK Santoni, P Tomasini和MB Palmaro
菜单